Austrian Federal Office for Safety in Health Care

Recent updates

Here you can find new page content of the last 4 weeks.

News

Information about the new withdrawal period of Toltrazuril New

Safety warnings | Veterinary Medicines | 31/01/2023
Important information from the Federal Office for Public Health Safety on the new withdrawal period for veterinary medicinal products containing Toltrazuril for oral administration to chickens.
Information about the new withdrawal period of Toltrazuril Read more

Diprophos and Celestan New

Recall | Medicines | 27/01/2023
Recall due to possible stainless steel particles
Diprophos and Celestan Read more
News

CHMP Meeting Highlights December 2022

CHMP Monthly News | 09/01/2023
Up-to-date information from the November 12.12.-15.12.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights December 2022 Read more

Safety information on the quality defect/recall „BRONCHOSTOP Erkältungssaft“

Safety warnings | Medicines | 30/12/2022
Further information an safety information on the quality defect/recall „BRONCHOSTOP Erkältungssaft“
Safety information on the quality defect/recall „BRONCHOSTOP Erkältungssaft“ Read more

„Allergovit“ Short Ragweed 100% AT

Recall | Medicines | 30/12/2022
Recall due to mislabelling
„Allergovit“ Short Ragweed 100% AT Read more

BRONCHOSTOP Erkältungssaft

Recall | Medicines | 29/12/2022
Recall due to possible contamination with glass splinters
BRONCHOSTOP Erkältungssaft Read more

European Sperm Bank – donor-25203 MUGGIE

Safety warnings | Blood & Tissue | 27/12/2022
The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank European Sperm Bank (DK257572) that a male offspring of donor-25203 MUGGIE-has been diagnosed with global developmental delay, decreased liver function, and abnormal glycosylation.
European Sperm Bank – donor-25203 MUGGIE Read more

Information

COVID-19

Here you will find an overview of BASG information on prevention and treatment of COVID-19, as well as links to additional websites.

COVID-19 read more
Shortages

Shortages

Based on reports from pharmaceutical companies, BASG informs about current shortages.

Shortages read more
Reporting to BASG

Reporting to BASG

The Federal Office relies on reports from consumers, health care professionals and companies for the continuous re-evaluation of the safety profile of medicinal products and medical devices.

Reporting to BASG read more
Online form for adverse reactions

Online form for adverse reactions

The reporting of suspected adverse reactions to vaccines and medicinal
products is possible using a patient-friendly online form.

Online form for adverse reactions read more
Austrian Medicinal Product Index

Austrian Medicinal Product Index

The medicinal products database contains all products authorised in Austria, including up-to-date product information leaflets and the summary of products characteristics.

Austrian Medicinal Product Index read more

For Consumers

This is the subpage with information from the BASG directed to consumers (patients, their relatives and owners of animals).

read more

For Health Care Professionals

This is the subpage with information from the BASG directed to health care professionals (physicians, dentists, veterinarians, midwives and pharmacists).

read more

For Companies

This is the subpage with information by the BASG directed to companies producing, controlling or distributing medicinal products or medical devices.

read more

Market Surveillance

This is the subpage with the official announcements and public databases provided by the BASG as well as procedures for reporting to BASG.

read more